Search Results - Sun, Huahang

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

    The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins by Lu, Gang, Middleton, Richard E., Sun, Huahang, Naniong, MarkVic, Ott, Christopher J., Mitsiades, Constantine S., Wong, Kwok-Kin, Bradner, James E., Kaelin, William G.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis

    Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis by Maxson, Julia E, Abel, Melissa L, Wang, Jinhua, Deng, Xianming, Reckel, Sina, Luty, Samuel B, Sun, Huahang, Gorenstein, Julie, Hughes, Seamus B, Bottomly, Daniel, Wilmot, Beth, McWeeney, Shannon K, Radich, Jerald, Hantschel, Oliver, Middleton, Richard E, Gray, Nathanael S, Druker, Brian J, Tyner, Jeffrey W

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Development and Repurposing of Small-Molecule Kinase Inhibitors to Target Novel Leukemogenic TNK2 Mutations

    Development and Repurposing of Small-Molecule Kinase Inhibitors to Target Novel Leukemogenic TNK2 Mutations by Maxson, Julia Elizabeth, Melissa, Abel L, Wang, Jinhua, Deng, Xianming, Luty, Samuel B, Sun, Huahang, Gorenstein, Julie, Middleton, Richard, Gray, Nathanael S., Druker, Brian J., Tyner, Jeffrey W.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Identification and characterization of Tyrosine Kinase Non-receptor 2 mutations in leukemia through integration of kinase inhibitor screening and genomic analysis

    Identification and characterization of Tyrosine Kinase Non-receptor 2 mutations in leukemia through integration of kinase inhibitor screening and genomic analysis by Maxson, Julia E., Abel, Melissa L., Wang, Jinhua, Deng, Xianming, Reckel, Sina, Luty, Samuel B., Sun, Huahang, Gorenstein, Julie, Hughes, Seamus, Bottomly, Daniel, Wilmot, Beth, McWeeney, Shannon K., Radich, Jerald, Hantschel, Oliver, Middleton, Richard E, Gray, Nathanael S., Druker, Brian J., Tyner, Jeffrey W.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: